Wells Fargo Health Savings Accounts Grow to Quarter-Billi...(d holdsmore than $260 million on deposit...),Health
Navigation Links
Wells Fargo Health Savings Accounts Grow to Quarter-Billion Dollars
Date:5/19/2008
d holds more than $260 million on deposit for 150,000 account holders. Learn more at http://www.wellsfargo.com/hsa.
Wells Fargo & Company is a diversified financial services company with $595 billion in assets, providing banking, insurance, investments, mortgage and consumer finance through almost 6,000 stores and the internet (wellsfargo.com) across North America and internationally. Wells Fargo Bank, N.A. is the only bank in the U.S., and one of only two banks worldwide, to have the highest possible credit rating from both Moody's Investors Service, "Aaa," and Standard & Poor's Ratings Services, "AAA."
'/>"/>
| SOURCE Wells Fargo & Company Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Wells Fargo Offers Online Benefit Administration for Business and Individual Healthcare Consumers
2. DaVita to Open First Independent Dialysis Clinic in Fargo-Moorhead
3. Penn study finds pro-death proteins required to regulate healthy immune function
4. UCLA researchers identify markers that may predict diabetes in still-healthy people
5. Air pollution linked to cardiovascular risk indices in healthy young adults
6. More proof needed of safety and quality of electronic personal health records
7. Health care incentive model offers collaborative approach
8. Loneliness is bad for your health
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Green Tea May Brew Up Healthier Skin
11. For Health Info, Women Often Turn to the Web
Post Your Comments:
(Date:11/24/2009)...nts of salt is linked to a significantly higher ri... paper published today in the British Medical Jou... the World Health Organization,s Collaborating Cen...ick and University Hospital in Coventry, UK, and t...tre in Hypertension based at the Department of Cli...
(Date:11/24/2009)...LLS,Mich.,Nov.24/PRNewswire/--SkyFoundation,Inc.,a...ndresearchtodevelopabloodtestfortheearlydetectiono...t$100,000sinceitsinceptioninJune2008.Theannounceme...n,aftertheorganization,sfirstmajorfundraiser. ,...er8,atabrunchatTheVillageClubinBloomfieldHills,Mic...
(Date:11/24/2009)...24/PRNewswire/-- Asyear-endapproaches,manyemploye...yearandnext.Tohelpyoutakeadvantageofthesespecialta...lystatThomsonReuters,highlightsthefollowingkeyyear...althflexiblespendingaccounts(HealthFSAs) . Manye...axesbyplacingfundsintheiremployer,shealthFSA.These...
(Date:11/24/2009)...taking sedatives, antidepressants, benzodiazepines...lthDay News) -- Seniors who take antidepressants, ...e at increased risk for falls, a new review shows....tudies that included a total of 79,081 participant...s of drugs: high blood pressure medicines; diureti...
(Date:11/24/2009)...alif.,Nov.24/PRNewswire/--AgitoNetworks,Inc.,theco...lity,todayannouncedthatitwashonoredintheEverything...ywhereMobilityRouterv3.0.EverythingChannel,sTechIn...roducednewsolutionsthatdriveadvancesthroughoutthet...terreviewedhundredsofapplicationsforthe2009Everyth...
Breaking Medicine News(10 mins):Health News:High salt intake linked to strokes and cardiovascular disease 2Health News:Sky Foundation, Inc. Raises More Than $100,000 to Find a Test for Early Detection of Pancreatic Cancer 2Health News:The Right Tax Moves for Employees to Make Before Year-End 2Health News:The Right Tax Moves for Employees to Make Before Year-End 3Health News:Some Prescription Meds May Raise Seniors' Risks of Falling 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 3[0] High salt intake linked to strokes and cardiovascular disease[0] Sky Foundation, Inc. Raises More Than $100,000 to Find a Test for Early Detection of Pancreatic Cancer[0] The Right Tax Moves for Employees to Make Before Year-End[0] Some Prescription Meds May Raise Seniors' Risks of Falling [2] Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel
...Chat, Blogs, Events & More Benefit Online Nurse Co...ly designed for,business professionals to connect ...the Internet. Now there,s a Web site rising to the...rseconnect.com ) is a user-friendly site for colla...
...IDGE, Mass., Dec. 21 Millennium,Pharmaceuticals, ...on of a,supplemental new drug application (sNDA) w...r VELCADE in the treatment of patients with,previo...domized clinical trials for patients in this treat...
...SVILLE, Pa., Dec. 21 RESPIRONICS, INC.,(Nasdaq: ...itive merger,agreement pursuant to which Royal Phi...ill commence a tender offer to acquire all of the ...nts a,premium of approximately 31% over Respironic...
...O, Ohio, Dec. 20 Upon an ex parte motion,by the S...chigan (SEIU), a,temporary restraining order (TRO)...hirtieth Judicial Circuit Court in Ingham County, ...ed to,completing the pending transaction between M...
...NGTON, Dec. 20 The Campaign to End,Obesity (the C...mocratic,and Republican presidential candidates fa...ifically plans to address the Nation,s obesity epi...e,candidates, campaign offices in early November.,...
...NGTON, Dec. 20 Today URAC called for,comments on ... Health Web,Site, HIPAA Privacy (Business Associat... Associate and Covered Entity) accreditation progr...dline for public comment is Feb. 10, 2008., (LOGO...
Other Medicine News:Health News:Professional Networking Web Site, NurseConnect.com Launches Innovative Features 2Health News:Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma 2Health News:Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma 3Health News:Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma 4Health News:Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma 5Health News:Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share 2Health News:Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share 3Health News:Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share 4Health News:Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share 5Health News:Manor Care To Vigorously Contest TRO 2Health News:2008 Presidential Hopefuls Fail to Respond to Questions About Obesity in U.S. 2Health News:URAC Calls for Comments on Changes to Standards for Health Web Site, HIPAA Privacy and Security Accreditation Programs 2Professional Networking Web Site, NurseConnect.com Launches Innovative FeaturesMillennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple MyelomaRoyal Philips Electronics to Acquire Respironics for USD $66.00 Per ShareManor Care To Vigorously Contest TRO2008 Presidential Hopefuls Fail to Respond to Questions About Obesity in U.S.URAC Calls for Comments on Changes to Standards for Health Web Site, HIPAA Privacy and Security Accreditation Programs
(Date:11/24/2009)...TSBURGH,Nov.24/PRNewswire/-- ,, WHAT:RomHoubens...winganautoaccident,wasactuallyfullyconsciousandawa...icasegment.TheDynaVoxEyeMaxwasfeaturedinthesegment...conditionscanunlockcommunication. ,, WHEN:GoodM...at www.dynavoxtech.com ,, WHO:RomHoubens...
(Date:11/24/2009)...DCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-- Ei...dDrugAdministration(FDA)hasacceptedforreviewEisai,...74;(donepezilHClextendedrelease)tabletsforthetreat...ewhigherdoseformulationcontains23mgofdonepezilHCli...ystemthatallowsforgradualreleaseofthedrug.TheNDAis...
(Date:11/24/2009)...EIGH,N.C.,Nov.24/PRNewswire/--PharmaceuticalInstit...forthepharmaceuticalandbiotechindustry,todayannoun...ace .Thenew HospitalMarketplace e-courseisthenewes...M) series,acomprehensiveseriesofe-coursesdesignedt...etsknowledgeforcommercialprofessionals. ,, Then...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2Brain Training Keeps Older Drivers Safe Behind the Wheel 57315 1Brain Training Keeps Older Drivers Safe Behind the Wheel 57315 2Brain Training Keeps Older Drivers Safe Behind the Wheel 57315 3BioSpecifics Technologies Corp Stock Trading Halted Today 14076 1GENova and TheraGlass in advanced negotiations 57312 1GENova and TheraGlass in advanced negotiations 57312 2GENova and TheraGlass in advanced negotiations 57312 3...--May 2, 2007 - Acorda Therapeutics, Inc.(R),(Nasd...ical trial,of Fampridine-SR in people with multipl...ogy meeting. Andrew Goodman, M.D.,Director of the...chester, presented top-line results on walking abi...ubject global impressions.,Dr. Goodman also presen...
...May 02, 2007 /PRNewswire-FirstCall/ --,Genelabs Te...on was,made today at the 20th International Confer...ngs, California, on a,non-nucleoside hepatitis C v...labs. , The oral presentation was given by Christo...istry at Genelabs, entitled,"GL59728: A Potent All...
Other Medicine Technology:Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 2Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |